The platelet-rich fibrin (PRF) is an autologous blood by-product that presents many growth factors/ cytokines to support the healing after a surgical procedure. Since the 2000s, the PRF has shown many studies demonstrating different protocols and clinical applications. In 2018, my group developed the Alb-CGF/ Alb-PRF, a new protocol based on the blood’s albumin. The present lecture aims to introduce and enrich the audience’s knowledge about blood by-products, especially on the Alb-PRF.
About Dr. Carlos Mourao, DDS :